This document discusses depression, including its DSM-V criteria, possible causes, treatments, and impact. It notes that major depression involves 5 out of 9 symptoms for at least 2 weeks. Possible causes discussed include monoamine, glutamate, and systemic hypotheses as well as trauma. Treatments mentioned range from SSRIs and SNRIs to ECT. The World Health Organization study found depression to be a leading cause of disability worldwide in 2004 and projected to remain so in 2030. The case of Ricardo, a veteran with traumatic brain injury, is also summarized.
2. DEPRESSION and its
possible causes
◦ A Personal experience
◦ DSM V criteria
◦ Sherwin Nuland video
◦ World Health Organization Study
◦ What Causes Depression?
-Monoamine hypothesis
-Glutamate hypothesis
-Systemic hypothesis
-Trauma
7/22/2013 2
4. DSM V DEFINITIONS
Major Depression (MDD) Five or more of
the following for 2 weeks or more:
-depressed mood
-anhedonia (loss of interest or pleasure)
-weight gain/loss
-insomnia/hypersomnia
-loss of energy
-feelings of worthlessness/guilt
-loss of concentration/decisiveness
-thoughts of death/suicide
-psychomotor agitation
7/22/2013 4
5. Sherwin Nuland presentation
Prominent surgeon at Yale-New
Haven hospital
Major breakdown at age 42
Presentation on the west coast in
2001
7/22/2013 5
7. WHAT IS THE IMPACT OF
DEPRESSION?
WORLD HEALTH ORGANIZATION
Global Burden of Disease
Leading Causes of Disability
2004 Survey
Unit of measurement= DALY
(Disability
Associated Life Year)
7/22/2013 7
8. 2004 2030
Lower respiratory
infections
Diarrheal diseases
Unipolar depression
Unipolar depression
Ischemic heart disease
Traffic accidents
WORLD HEALTH ORGANIZATION
Global Burden of Disease
Leading Causes of Disability
7/22/2013 8
11. Glutamatergic hypothesis:
Too much glutamate at the NMDA
receptor
Resulting in too much excitation in
the prefrontal cortex of the brain
7/22/2013 11
12. LIKELY SEQUENCE OF
TREATMENTS:
SSRIs (Prozac, Zoloft)
SNRIs (Cymbalta)
Atypical antidepressants
(bupropion/Wellbutrin)
Antiepileptics for mood control (valproic
acid, carbamazepine)
“cocktail” of foregoing
Psychotherapy concurrently
ECT
Ketamine
7/22/2013 12
13. ECT TREATMENT
1973 CASE:
“tangle of twisted wires in my head”
NIH: ECT seizures cause discharge of
neurotransmitters
HISTORY:
Discovered in 1938 in Rome
Precise mechanism unknown
Efficacy studies vary widely
CURRENT PRACTICE:
Sedation plus muscle relaxant
Pulsed was continuous
6 to 10 treatments over 2 to 3 weeks
Bitemporal, unilateral, bifrontal
Reported memory loss
7/22/2013 13
15. GLUTAMATERGIC SYSTEMSource: Machado-Vieira R & Zarate CA
Proof of Concept Trials in Bipolar Disorder and Major Depressive Disorder: A Translational Perspective in the Search for Improved Treatments
Published online 24 February 2011 in Wiley Online Library
7/22/2013 15
16. SYSTEMIC HYPOTHESIS
Bodily disorders destabilize the brain
Systemic inflammation
Vitamin/mineral deficiencies
Heavy metals toxicity
7/22/2013 16
21. RICARDO
A 12-B combat engineer who suffered
Traumatic Brain Injury in 2012 in
Afghanistan
22. RICARDO
U.S. citizen born in South America
H.S. grad, enlisted at 26 now 28
Wife and sons 6 and 7
No prior medical history
Afghanistan 2011-2012: 12B infantry
Combat engineer “search for explosives if
found detonate them”
Learned Pashto, conversed with villagers
Multiple IED exposures and unit casualties
Feb 2012: gunner on RG 31, near rollover-
Concussion 850.9, loss of consciousness
Currently in treatment for TBI in U.S.
23. CURRENT SYMPTOMS
photo sensitivity
nausea
headaches 2 x / day
poor sleep 4-5 hours
left ear tinnitus
……………………………………………..
dizziness
vertigo, anxiety
photophobia (wears sunglasses)
malaise/fatigue
Irritability
emotional lability
apathy
memory loss that began 3 months post
concussion
24. DIAGNOSES
Current:
Adjustment disorder with
anxiety and depression
Memory loss; post combat stress
symptoms
………………………………………………..
Per prior post:
PTSD not warranted
Depression not warranted
25. REFERENCES
2001 TED presentation- Sherwin Nuland on ECT
World Health Organization- Global Burden of Disease-
2004
Murrough JW and Charney DS Cracking the Moody
Brain: Lifting the mood with ketamine Nature Medicine
16.1384-1385 (2010)
Messer MM and Haller IV Maintenance Ketamine
Treatment Produces Long-Term Recovery from
Depression Primary Psychiatry 2010;17(4): 48-50
Murrough JW et al Safety and efficacy of repeated-dose
intravenous ketamine for treatment-resistant depression
http://www.ncbi.nlm.nih.gov/pubmed/19897179
Zarate CA et al A Randomized Add-on Trial of an N-
methyl-D aspartate Antagonist in Treatment-Resistant
Bipolar Depression Arch Gen Psychiatry 2010;67
(8):793-802
7/22/2013 25
26. REFERENCES cont’d
Stahl, Stephan. Essential
Psychopharmacology: The Prescriber’s
Guide. Cambridge University Press, New
York, NY 2008.
Herman, Judith. Trauma and Recovery. Basic
Books, NYC, NY 1997.
Doidge, Norman. The Brain That Changes
Itself. Penguin Books, London, England
2007.
Hyman, Mark. The Ultra Mind Solution.
Scribner, New York, NY 2009.
Restak, Richard. Optimizing Brain Fitness.
The Great Courses, Chantilly, VA. 2011.
7/22/2013 26